+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nuclear Medicine Market Research Report by Product, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5206422
  • Report
  • July 2021
  • Region: Global
  • 182 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Nuclear Medicine Market will Grow to USD 6,353.63 Million by 2026, at a CAGR of 7.14%

FEATURED COMPANIES

  • Bayer AG
  • BWX Technologies, Inc.
  • Eckert & Ziegler Group
  • IBA Molecular
  • Medtronic, Inc
  • Novartis AG
The Global Nuclear Medicine Market size was estimated at USD 4,198.71 Million in 2020 and expected to reach USD 4,484.62 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.14% to reach USD 6,353.63 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Nuclear Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Nuclear Medicine Market was studied across Diagnostic Products and Therapeutic Products. The Diagnostic Products is further studied across PET and SPECT. The Therapeutic Products is further studied across Alpha Emitters, Beta Emitters, and Brachytherapy.
  • Based on Application, the Nuclear Medicine Market was studied across Bone Metastasis, Cardiology, Endocrine Tumor, Lymphoma, Oncology, and Thyroid.
  • Based on Region, the Nuclear Medicine Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Nuclear Medicine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Nuclear Medicine Market, including Australian Nuclear Science & Technology Organization, Bayer AG, Bracco Imaging S.P.A., BWX Technologies, Inc., Cardinal Health, Inc., Curium by CapVest Associates, Eckert & Ziegler Group, Eczacibasi-Monrol Nuclear Products, GE Healthcare, Global Medical Solutions, Ltd., IBA Molecular, Institute of Isotopes Co., Ltd., Isotopia Molecular Imaging Limited, Joint Stock Company Isotope, Jubilant Draximage, Inc., Lantheus Medical Imaging, Inc., Medtronic, Inc, Nordion, Inc, Northstar Medical Radioisotopes, LLC, Novartis AG, NTP Radioisotopes Soc, Ltd., PharmaLogic Holdings Corp, Shine Medical Technologies, and Sinotau Pharmaceuticals Group.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Nuclear Medicine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Nuclear Medicine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Nuclear Medicine Market?
4. What is the competitive strategic window for opportunities in the Global Nuclear Medicine Market?
5. What are the technology trends and regulatory frameworks in the Global Nuclear Medicine Market?
6. What is the market share of the leading vendors in the Global Nuclear Medicine Market?
7. What modes and strategic moves are considered suitable for entering the Global Nuclear Medicine Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • BWX Technologies, Inc.
  • Eckert & Ziegler Group
  • IBA Molecular
  • Medtronic, Inc
  • Novartis AG
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Application Outlook
3.5. Region Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of procedures to diagnose and treat cancer
5.1.1.2. Application of alpha radioimmunotherapy-based targeted cancer treatment
5.1.1.3. Rising demand for better medical solutions
5.1.2. Restraints
5.1.2.1. Short half-life of nuclear medicine
5.1.3. Opportunities
5.1.3.1. Nuclear pharmaceuticals used in neurological applications
5.1.3.2. Rising approach to measure in vivo physiology, biochemistry, and metabolism
5.1.4. Challenges
5.1.4.1. Lack of awareness about the related benefits among patients, physician education, and awareness
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Nuclear Medicine Market, by Product
6.1. Introduction
6.2. Diagnostic Products
6.2.1. PET
6.2.1.1. F-18
6.2.1.2. SR-82/RB-82
6.2.2. SPECT
6.2.2.1. GA-67
6.2.2.2. I-123
6.2.2.3. TC-99m
6.2.2.4. TL-201
6.3. Therapeutic Products
6.3.1. Alpha Emitters
6.3.1.1. RA-223
6.3.2. Beta Emitters
6.3.2.1. I-131
6.3.2.2. Lu-117
6.3.2.3. Re-186
6.3.2.4. SM-153
6.3.2.5. Y-90
6.3.3. Brachytherapy
6.3.3.1. Cesium-131
6.3.3.2. Iodine-125
6.3.3.3. Iridium-192
6.3.3.4. Palladium-103

7. Nuclear Medicine Market, by Application
7.1. Introduction
7.2. Bone Metastasis
7.3. Cardiology
7.4. Endocrine Tumor
7.5. Lymphoma
7.6. Oncology
7.7. Thyroid

8. Americas Nuclear Medicine Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Nuclear Medicine Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Nuclear Medicine Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Australian Nuclear Science & Technology Organization
12.2. Bayer AG
12.3. Bracco Imaging S.P.A.
12.4. BWX Technologies, Inc.
12.5. Cardinal Health, Inc.
12.6. Curium by CapVest Associates
12.7. Eckert & Ziegler Group
12.8. Eczacibasi-Monrol Nuclear Products
12.9. GE Healthcare
12.10. Global Medical Solutions, Ltd.
12.11. IBA Molecular
12.12. Institute of Isotopes Co., Ltd.
12.13. Isotopia Molecular Imaging Limited
12.14. Joint Stock Company Isotope
12.15. Jubilant Draximage, Inc.
12.16. Lantheus Medical Imaging, Inc.
12.17. Medtronic, Inc
12.18. Nordion, Inc
12.19. Northstar Medical Radioisotopes, LLC
12.20. Novartis AG
12.21. NTP Radioisotopes Soc, Ltd.
12.22. PharmaLogic Holdings Corp
12.23. Shine Medical Technologies
12.24. Sinotau Pharmaceuticals Group

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL NUCLEAR MEDICINE MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL NUCLEAR MEDICINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2026
FIGURE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RA-223, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RA-223, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, 2018-2026 (USD MILLION)
FIGURE 38. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 39. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, 2018-2026 (USD MILLION)
FIGURE 40. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 41. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, 2018-2026 (USD MILLION)
FIGURE 42. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 43. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, 2018-2026 (USD MILLION)
FIGURE 44. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 45. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, 2018-2026 (USD MILLION)
FIGURE 46. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 47. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2026 (USD MILLION)
FIGURE 48. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 49. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, 2018-2026 (USD MILLION)
FIGURE 50. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 51. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, 2018-2026 (USD MILLION)
FIGURE 52. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 53. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, 2018-2026 (USD MILLION)
FIGURE 54. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 55. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, 2018-2026 (USD MILLION)
FIGURE 56. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 57. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 58. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 59. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2026
FIGURE 60. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, 2018-2026 (USD MILLION)
FIGURE 61. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 62. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2026 (USD MILLION)
FIGURE 63. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 64. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, 2018-2026 (USD MILLION)
FIGURE 65. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 66. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, 2018-2026 (USD MILLION)
FIGURE 67. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 68. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
FIGURE 69. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 70. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, 2018-2026 (USD MILLION)
FIGURE 71. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 72. AMERICAS NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. BRAZIL NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. CANADA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. MEXICO NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 79. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 80. CHINA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 81. INDIA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 82. INDONESIA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 83. JAPAN NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 84. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 85. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 86. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 87. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 88. THAILAND NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 89. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 90. FRANCE NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 91. GERMANY NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 92. ITALY NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 93. NETHERLANDS NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 94. QATAR NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 95. RUSSIA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 96. SAUDI ARABIA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 97. SOUTH AFRICA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 98. SPAIN NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 99. UNITED ARAB EMIRATES NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 100. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 101. GLOBAL NUCLEAR MEDICINE MARKET: FPNV POSITIONING MATRIX
FIGURE 102. GLOBAL NUCLEAR MEDICINE MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 103. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NUCLEAR MEDICINE MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL NUCLEAR MEDICINE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RA-223, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2018-2026 (USD MILLION)
TABLE 26. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2018-2026 (USD MILLION)
TABLE 27. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2018-2026 (USD MILLION)
TABLE 28. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 29. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 31. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2018-2026 (USD MILLION)
TABLE 32. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2026 (USD MILLION)
TABLE 33. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 34. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2018-2026 (USD MILLION)
TABLE 35. AMERICAS NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. BRAZIL NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. CANADA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. MEXICO NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. CHINA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. INDIA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. INDONESIA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. JAPAN NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. THAILAND NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. FRANCE NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. GERMANY NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 55. ITALY NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 56. NETHERLANDS NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 57. QATAR NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 58. RUSSIA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 59. SAUDI ARABIA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 60. SOUTH AFRICA NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 61. SPAIN NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 62. UNITED ARAB EMIRATES NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 63. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 64. GLOBAL NUCLEAR MEDICINE MARKET: SCORES
TABLE 65. GLOBAL NUCLEAR MEDICINE MARKET: BUSINESS STRATEGY
TABLE 66. GLOBAL NUCLEAR MEDICINE MARKET: PRODUCT SATISFACTION
TABLE 67. GLOBAL NUCLEAR MEDICINE MARKET: RANKING
TABLE 68. GLOBAL NUCLEAR MEDICINE MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 69. GLOBAL NUCLEAR MEDICINE MARKET: MERGER & ACQUISITION
TABLE 70. GLOBAL NUCLEAR MEDICINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 71. GLOBAL NUCLEAR MEDICINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 72. GLOBAL NUCLEAR MEDICINE MARKET: INVESTMENT & FUNDING
TABLE 73. GLOBAL NUCLEAR MEDICINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 74. GLOBAL NUCLEAR MEDICINE MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Australian Nuclear Science & Technology Organization
  • Bayer AG
  • Bracco Imaging S.P.A.
  • BWX Technologies, Inc.
  • Cardinal Health, Inc.
  • Curium by CapVest Associates
  • Eckert & Ziegler Group
  • Eczacibasi-Monrol Nuclear Products
  • GE Healthcare
  • Global Medical Solutions, Ltd.
  • IBA Molecular
  • Institute of Isotopes Co., Ltd.
  • Isotopia Molecular Imaging Limited
  • Joint Stock Company Isotope
  • Jubilant Draximage, Inc.
  • Lantheus Medical Imaging, Inc.
  • Medtronic, Inc
  • Nordion, Inc
  • Northstar Medical Radioisotopes, LLC
  • Novartis AG
  • NTP Radioisotopes Soc, Ltd.
  • PharmaLogic Holdings Corp
  • Shine Medical Technologies
  • Sinotau Pharmaceuticals Group
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll